Imricor Medical Systems, Inc.: Maastricht Univerisity Medical Center Commences Procedures
Company or
Imricor) (
ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce the Maastricht University Medical Centre+ (
MUMC+) in the Netherlands has commenced procedures since the extended lockdowns across Europe precluded elective surgeries. The team at MUMC+ successfully performed two atrial flutter ablations yesterday.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210224006030/en/
Dr. Marisevi Chaldoupi performing an atrial flutter ablation with Imricor s products at MUMC+ in a standard MRI suite equipped to function as an iCMR lab (Photo: Business Wire)